Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Shares Could Be 28% Below Their Intrinsic Value Estimate

Key Insights Longboard Pharmaceuticals' estimated fair value is US$35.05 based on 2 Stage Free Cash Flow to Equity...

Related Keywords

United States ,American , ,Analysis For Longboard Pharmaceuticals ,Longboard Pharmaceuticals ,For Longboard Pharmaceuticals ,Solid Businesses ,Discounted Cash Flow ,Uture Cash Flows ,Free Cash Flow ,Resent Value ,Ntrinsic Value ,Nc ,Erminal Value ,Cf ,Bph ,Company ,